NEW YORK (GenomeWeb) – The National Institutes of Health will award up to $5 million next fiscal year to fund one or two research teams that will use a range of biomarker typesto identify the progression of Alzheimer's disease in adults who have Down syndrome.

Adults with Down syndrome are at "extremely high risk" of developing AD, NIH said in a funding announcement on Friday. These projects will seek to characterize the longitudinal trajectory of AD-related genetic, biochemical, imaging, clinical, and cognitive biomarkers in adults with Down syndrome.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

The president of France's National Research Agency has resigned, according to Nature News.

A senator wants a "right-to-try" provision in the US Food and Drug Administration funding bill, but an ethicist says at Stat News that it would undermine the role of clinical trials.

The Guardian's Barbara Ellen has tried out some DNA testing services to see whether they provide valuable information.

In PNAS this week: red algae Porphyra umbicalis genome, deep neural network model for sequencing peptides, and more.